CN117257911A - 一种水产肠道肝胆修复制剂 - Google Patents
一种水产肠道肝胆修复制剂 Download PDFInfo
- Publication number
- CN117257911A CN117257911A CN202311481357.1A CN202311481357A CN117257911A CN 117257911 A CN117257911 A CN 117257911A CN 202311481357 A CN202311481357 A CN 202311481357A CN 117257911 A CN117257911 A CN 117257911A
- Authority
- CN
- China
- Prior art keywords
- extract
- gall
- preparation
- ginger
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004185 liver Anatomy 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 31
- 210000001035 gastrointestinal tract Anatomy 0.000 title claims abstract description 22
- 239000000284 extract Substances 0.000 claims abstract description 88
- 229940098465 tincture Drugs 0.000 claims abstract description 43
- 241001092040 Crataegus Species 0.000 claims abstract description 37
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 37
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 37
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 37
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 37
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 37
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 37
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 37
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 37
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 37
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 37
- 239000000463 material Substances 0.000 claims abstract description 31
- 241000132012 Atractylodes Species 0.000 claims abstract description 29
- 235000020708 ginger extract Nutrition 0.000 claims abstract description 26
- 229940002508 ginger extract Drugs 0.000 claims abstract description 25
- 241001061264 Astragalus Species 0.000 claims abstract description 11
- 235000006533 astragalus Nutrition 0.000 claims abstract description 11
- 210000004233 talus Anatomy 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 108
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 84
- 238000000605 extraction Methods 0.000 claims description 39
- 238000001914 filtration Methods 0.000 claims description 32
- 239000000203 mixture Substances 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 229920002472 Starch Polymers 0.000 claims description 21
- 230000000968 intestinal effect Effects 0.000 claims description 21
- 239000008107 starch Substances 0.000 claims description 21
- 235000019698 starch Nutrition 0.000 claims description 21
- 241000234314 Zingiber Species 0.000 claims description 20
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 20
- 235000008397 ginger Nutrition 0.000 claims description 20
- 240000002234 Allium sativum Species 0.000 claims description 19
- 235000004611 garlic Nutrition 0.000 claims description 19
- 229940107666 astragalus root Drugs 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 16
- 239000000047 product Substances 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 15
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 claims description 14
- 235000010081 allicin Nutrition 0.000 claims description 14
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 13
- 235000007106 Crataegus suborbiculata Nutrition 0.000 claims 1
- 241000073432 Crataegus suborbiculata Species 0.000 claims 1
- 235000013202 a hawthorn Nutrition 0.000 claims 1
- 241000251468 Actinopterygii Species 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 13
- 230000036039 immunity Effects 0.000 abstract description 3
- 210000000232 gallbladder Anatomy 0.000 abstract description 2
- 241000276707 Tilapia Species 0.000 description 9
- 208000004232 Enteritis Diseases 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 230000007413 intestinal health Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000010649 ginger oil Substances 0.000 description 3
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 3
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 241000157862 Dicamptodontidae Species 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000002780 gingerol Nutrition 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 241000522190 Desmodium Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000218671 Ephedra Species 0.000 description 1
- 108010028690 Fish Proteins Proteins 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000334154 Isatis tinctoria Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000361919 Metaphire sieboldi Species 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Natural products OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 241000212749 Zesius chrysomallus Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- -1 compound vitamin Chemical class 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 238000009372 pisciculture Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000003911 water pollution Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于新材料领域,具体涉及一种水产肠道肝胆修复制剂,包括主料、生姜提取物、大蒜素、山楂酊;所述主料为白术、黄芪的提取物;所述主料、生姜提取物、大蒜素、山楂酊的重量比为1000:10~100:10~20:10~50。该制剂可以有效的提高鱼类免疫力,提高对于转塘鱼、应激鱼的产肠道肝胆的修复功效。
Description
技术领域
本发明属于新材料领域,具体涉及一种水产肠道肝胆修复制剂。
背景技术
CN114470084A公开了一种环保高效防治罗非鱼白便的组合物及其制备方法和应用,组合物包括白术、茯苓、黄芪、山药、甘草,制备方法采用复合酶酶解方法和水提醇沉方法相结合,通过复合酶把细胞膜、细胞质内的淀粉多糖、糖蛋白酶解,使得药用多糖更好地释放,再采用水提醇沉的方法把药用多糖浸提、浓缩、沉淀分离出来,最终得到效价高、方便使用、便于保存的提取物。通过从一种中药组合物中提取植物多糖,作为益生元,常温易保存,稳定性好,可用于饲料加工,直达肠道,作为肠道菌群的碳源促进肠道有益菌的增殖、抑制有害菌,从而改善肠道微生态菌群,维持平衡的菌群结构,有利于防治罗非鱼白便和肠炎问题。
CN107594136A公开了一种促进吸收的娃娃鱼饲料,其原料按重量份包括:鱼蛋白粉20-30份,猪肝10-15份,蚯蚓粉10-12份,虾粉8-10份,蛙肉粉6-8份,牛肉膏4-6份,小麦粉10-15份,豆粕6-8份,大豆油6-8份,芝麻油4-6份,复合维生素粉1-2份,复合矿物质粉1-2份,果胶3-5份,羧甲基纤维素6-8份,氯化钙2-3份,益生菌3-5份,海藻酸钠8-10份,添加剂10-15份,复合酶2-4份,柠檬酸0.3-0.5份;其中,添加剂的原料包括:胡萝卜素、芝麻酚、角鲨烯、蒲公英水提物、大青叶水提物、黄芪水提物、白术水提物。能促进肠道消化吸收养分,并缓解肝脏负荷,促进娃娃鱼快速健康生长。
CN104938818A公开了一种保护罗非鱼肠道健康的复方中草药饲料添加剂,其包括有以下重量百分比的组分:黄芪18-25%、野菊花15-18%、金钱草4-7%、草麻黄9-15%、白术16-19%、当归20-30%、甘草5%。其能够提高罗非鱼肠道健康,增加罗非鱼消化吸收能力,提高成活率,降低饵料系数,减少水质污染。
对于鱼类养殖来说,肝胆肠道疾病是非常常见的,是控制养殖成本的一个重要的方面。
所以,本案解决的技术问题是:如何有效的提高鱼类肝胆肠道健康。
发明内容
针对现有技术的不足,本发明的目的在于提供一种水产肠道肝胆修复制剂,该制剂可以有效的提高鱼类免疫力,提高对于转塘鱼、应激鱼的产肠道肝胆的修复功效。
为达到本发明目的,本发明采用以下技术方案:
一种水产肠道肝胆修复制剂,包括主料、生姜提取物、大蒜素、山楂酊;所述主料为白术、黄芪的提取物;
所述主料、生姜提取物、大蒜素、山楂酊的重量比为1000:10~100:10~20:10~50。
在上述的水产肠道肝胆修复制剂中,所述主料的制备方法为:将3000g白术和黄芪以干燥饮片的形式加水煎煮2次,合并煎液,过滤,加入乙醇使醇含量为60%,静置,分取上清液,滤过,回收乙醇,浓缩成为相对密度为1.05~1.1的浓缩膏;所述白术、黄芪的质量比为1:1~3。
在上述的水产肠道肝胆修复制剂中,所述主料、生姜提取物、大蒜素、山楂酊的重量比为1000:20~70:12~16:20~40。
在上述的水产肠道肝胆修复制剂中,将浓缩膏、生姜提取物、大蒜素、山楂酊、辅料混合,制粒;所述辅料为淀粉。
同时,本发明还公开了另外一种形式的水产肠道肝胆修复制剂,包括主料、生姜大蒜混合提取物、山楂酊;所述主料为白术、黄芪的提取物;
所述主料、生姜大蒜混合提取物、山楂酊的重量比为1000:10~100:10~50。
在上述的产肠道肝胆修复制剂中,所述生姜大蒜混合提取物的提取方法为:将新鲜的生姜、大蒜按照5:1~3的比例混合,采用粉碎机粉碎成混合物,采用90-95vol%的乙醇、乙酸乙酯作为提取溶剂提取混合物;乙醇、乙酸乙酯的体积比为6~9:1~4;混合物和提取溶剂的重量比为1:5~10;提取温度低于40℃,提取时间为3~5h;提取结束后经过滤、真空浓缩得到浸膏,将浸膏分散到乙酸乙酯中进行萃取,收集萃取后的油相,减压蒸馏去除乙酸乙酯,得到生姜大蒜混合提取物。
在上述的产肠道肝胆修复制剂中,乙醇、乙酸乙酯的体积比为7~8:2~3;混合物和提取溶剂的重量比为1:6~8。
在上述的产肠道肝胆修复制剂中,所述主料的制备方法为:将3000g白术和黄芪以干燥饮片的形式加水煎煮2次,合并煎液,过滤,加入乙醇使醇含量为60%,静置,分取上清液,滤过,回收乙醇,浓缩成为相对密度为1.05~1.1的浓缩膏所述白术、黄芪的质量比为1:1-3。
在上述的产肠道肝胆修复制剂中,将浓缩膏、生姜大蒜混合提取物、山楂酊、辅料混合,制粒;所述辅料为淀粉。
相对于现有技术,本发明具有以下有益效果:
本发明采用白术、黄芪作为载体药,采用生姜提取物、大蒜素、山楂酊来进行肝胆肠道的修复。
白术黄芪汤为较为有名的中医方剂。出自《宣明论方》卷九。具有清热燥湿,泻火解毒,补血活血,除烦止咳,温中散寒,益气补中,健脾养胃之功效。主治五心烦热,自汗,四肢痿劣,饮食减少,肌瘦昏昧。
当其应用到鱼类养殖中后,白术能增强吞噬功能,并且可提高淋巴细胞转化率,黄芪性甘微温,补中益气,偏补脾阳,可治脾虚泄泻。作为佐剂,生姜提取物含6-姜辣素具有抗氧化活性、抑制血小板聚集、保护胃黏膜等功效;大蒜素具有抗菌、诱食、抗氧化等多重功效(参考中国科学院海洋研究所科技情报研究室.《生物饵料增养殖技术与人工配合饵料》:中国科学院海洋研究所科技情报研究室,2010:219-210),山楂酊富含枸橼酸,其可以提高采食量促进营养物质消化吸收、促进肠道菌群健康、增强机体抗应激和免疫能力;
通过以上组合,可以提高白术、黄芪对于鱼类肠道肝胆健康的改善作用。
具体实施方式
下面通过具体实施方式来进一步说明本发明的技术方案。本领域技术人员应该明了,所述实施例仅仅是帮助理解本发明,不应视为对本发明的具体限制。
实施例1
步骤1:将1500g白术和1500g黄芪以干燥饮片的形式加水煎煮2次,合并煎液,过滤,加入乙醇使醇含量为60%,静置,分取上清液,滤过,回收乙醇,浓缩成为相对密度为1.05~1.1的浓缩膏;
步骤2:取浓缩膏、生姜提取物、大蒜素、山楂酊、淀粉,进行制粒;
浓缩膏、生姜提取物、大蒜素、山楂酊的重量比分别为:1000:50:15:30;
淀粉用量相当于浓缩膏、生姜提取物、大蒜素、山楂酊总重的2倍。
命名为样品1。
实施例2
步骤1:将1500g白术和1500g黄芪以干燥饮片的形式加水煎煮2次,合并煎液,过滤,加入乙醇使醇含量为60%,静置,分取上清液,滤过,回收乙醇,浓缩成为相对密度为1.05~1.1的浓缩膏;
步骤2:取浓缩膏、生姜提取物、大蒜素、山楂酊、淀粉,进行制粒;
浓缩膏、生姜提取物、大蒜素、山楂酊的重量比分别为:1000:100:10:50。
淀粉用量相当于浓缩膏、生姜提取物、大蒜素、山楂酊总重的2倍。
实施例3
步骤1:将1500g白术和1500g黄芪以干燥饮片的形式加水煎煮2次,合并煎液,过滤,加入乙醇使醇含量为60%,静置,分取上清液,滤过,回收乙醇,浓缩成为相对密度为1.05~1.1的浓缩膏;
步骤2取浓缩膏、生姜提取物、大蒜素、山楂酊、淀粉进行;
浓缩膏、生姜提取物、大蒜素、山楂酊的重量比分别为:1000:20:20:20。
淀粉用量相当于浓缩膏、生姜提取物、大蒜素、山楂酊总重的2倍。
实施例1-3中各原料来源为:
生姜提取物规格:粉末状,含1wt%姜辣素;
大蒜素:有效成分≥99%;
山楂酊:由湖北朗博万生物医药有限公司提供,浸膏。
实施例4
步骤1:将1500g白术和1500g黄芪以干燥饮片的形式加水煎煮2次,合并煎液,过滤,加入乙醇使醇含量为60%,静置,分取上清液,滤过,回收乙醇,浓缩成为相对密度为1.05~1.1的浓缩膏;
步骤2:将新鲜的生姜、大蒜按照5:2的重量比例混合,采用粉碎机粉碎成混合物,采用95vol%的乙醇、乙酸乙酯作为提取溶剂提取混合物;
乙醇、乙酸乙酯的体积比为8:2;混合物和提取溶剂的重量比为1:8;提取温度25℃,提取时间为4h;
提取结束后经过滤、真空浓缩得到浸膏,将浸膏分散到乙酸乙酯中进行萃取,收集萃取后的油相,减压蒸馏去除乙酸乙酯,得到生姜大蒜混合提取物。浸膏和乙酸乙酯的重量比为1:10。
步骤3:将步骤1的浓缩膏、生姜大蒜混合提取物、山楂酊的重量比为1000:75:20的比例混合,并加入淀粉制粒,淀粉的用量为浓缩膏、生姜大蒜混合提取物、山楂酊总重的2倍。
命名为样品2。
实施例5
步骤1:将1500g白术和1500g黄芪以干燥饮片的形式加水煎煮2次,合并煎液,过滤,加入乙醇使醇含量为60%,静置,分取上清液,滤过,回收乙醇,浓缩成为相对密度为1.05~1.1的浓缩膏;
步骤2:将新鲜的生姜、大蒜按照5:3的重量比例混合,采用粉碎机粉碎成混合物,采用90vol%的乙醇、乙酸乙酯作为提取溶剂提取混合物;
乙醇、乙酸乙酯的体积比为6:4;混合物和提取溶剂的重量比为1:10;提取温度25℃,提取时间为4h;
提取结束后经过滤、真空浓缩得到浸膏,将浸膏分散到乙酸乙酯中进行萃取,收集萃取后的油相,减压蒸馏去除乙酸乙酯,得到生姜大蒜混合提取物。浸膏和乙酸乙酯的重量比为1:10。
步骤3:将步骤1的浓缩膏、生姜大蒜混合提取物、山楂酊的重量比为1000:50:50的比例混合,并加入淀粉制粒,淀粉的用量为浓缩膏、生姜大蒜混合提取物、山楂酊总重的2倍。
实施例6
步骤1:将1500g白术和1500g黄芪以干燥饮片的形式加水煎煮2次,合并煎液,过滤,加入乙醇使醇含量为60%,静置,分取上清液,滤过,回收乙醇,浓缩成为相对密度为1.05~1.1的浓缩膏;
步骤2:将新鲜的生姜、大蒜按照5:1的重量比例混合,采用粉碎机粉碎成混合物,采用95vol%的乙醇、乙酸乙酯作为提取溶剂提取混合物;
乙醇、乙酸乙酯的体积比为9:1;混合物和提取溶剂的重量比为1:6;提取温度25℃,提取时间为4h;
提取结束后经过滤、真空浓缩得到浸膏,将浸膏分散到乙酸乙酯中进行萃取,收集萃取后的油相,减压蒸馏去除乙酸乙酯,得到生姜大蒜混合提取物。浸膏和乙酸乙酯的重量比为1:10。
步骤3:将步骤1的浓缩膏、生姜大蒜混合提取物、山楂酊的重量比为1000:10:10的比例混合,并加入淀粉制粒,淀粉的用量为浓缩膏、生姜大蒜混合提取物、山楂酊总重的2倍。
实施例7
大体同实施例4,不同的地方在于,提取溶剂变成95vol%的乙醇。
命名为样品3。
实施例8
大体同实施例4,不同的地方在于,提取溶剂变成乙酸乙酯。
命名为样品4。
对比例1
步骤1:将1500g白术和1500g黄芪以干燥饮片的形式加水煎煮2次,合并煎液,过滤,加入乙醇使醇含量为60%,静置,分取上清液,滤过,回收乙醇,浓缩成为相对密度为1.05~1.1的浓缩膏;
步骤2:取浓缩膏、生姜提取物、山楂酊、淀粉制粒;
浓缩膏、生姜提取物、山楂酊的重量比分别为:1000:60:35。
淀粉用量相当于浓缩膏、生姜提取物、山楂酊总重的2倍。
命名为样品5。
对比例2
步骤1:将1500g白术和1500g黄芪以干燥饮片的形式加水煎煮2次,合并煎液,过滤,加入乙醇使醇含量为60%,静置,分取上清液,滤过,回收乙醇,浓缩成为相对密度为1.05~1.1的浓缩膏;
步骤2:取浓缩膏、生姜提取物、大蒜素、淀粉制粒;
浓缩膏、生姜提取物、大蒜素的重量比分别为:1000:75:20。
命名为样品6。
对比例3
步骤1:将1500g白术和1500g黄芪以干燥饮片的形式加水煎煮2次,合并煎液,过滤,加入乙醇使醇含量为60%,静置,分取上清液,滤过,回收乙醇,浓缩成为相对密度为1.05~1.1的浓缩膏;
步骤2:取浓缩膏、大蒜素、山楂酊、淀粉制粒;
浓缩膏、大蒜素、山楂酊的重量比分别为:1000:30:65。
命名为样品7。
养殖实验
在广东省某养殖场进行养殖实验,实验所用的养殖对象为200g±10g的罗非鱼苗960尾,分为8组(A组~H组),每组4个重复,每个重复30尾,在20个室内循环流水过滤养殖池中进行养殖;水温平均为28.0±2.0℃,水中溶氧大于7mg/L,氨氮低于0.5mg/L,每天光照时间为12h;按鱼体重的3%作为每日投饲量,每天上午9h和下午4h分2次投喂,按日增重2%计总体重,每7天调整一次投饲量,试验期为6周;养殖周期内无罗非鱼死亡。
投喂的基础饲料采用某品牌罗飞浮水饲料,每吨饲料加入1.5kg水产肠道肝胆修复制剂。
A组为空白组,仅投喂基础饲料;
B组为基础饲料+样品1;
C组为基础饲料+样品2;
D组为基础饲料+样品3;
E组为基础饲料+样品4;
F组为基础饲料+样品5;
G组为基础饲料+样品6;
H组为基础饲料+样品7;
养殖周期结束后,各养殖池中无鱼苗死亡;对各养殖池的鱼苗进行称重,计算平均日增重、肝胆综合症发生情况、肠炎发生情况和白便情况。
平均日增重:计算实验开始和结束的时候的重量差值,再除以实验天数;
肝胆综合症的判定:病鱼尾鳍、背鳍的鳍条尖发白,体表其他无任何明显症状,病鱼的口腔及眼球周围均无明显症状;将活的病鱼提起,有少量血液从鳃盖下方流出鳃部有大量的淤血,黏液增多,鳃丝充血;肝脏轻触易碎,肿大,有点状或块状出血或瘀血,色泽变淡,呈土黄色,或发白,形成黄白相间的“花肝”;肠道外壁无明显症状,但内壁却严重充血,肠道弹性很差,肠道中有少量的食物。
肠炎的判定:病鱼游动缓慢或呆立不动,体色灰暗,离群独游,食欲减退,慢游水边或浮于水面。病鱼腹部膨大并带有红斑,肛门红肿,呈紫红色,轻压腹部有血和黄色黏液外流。剖开腹部,可见肠管充血腐烂,多脓液,局部发炎,充满黏液,无食物,肠壁弹性差,剪开肠道发现肠壁变白、较薄,肠道的内黏膜脱落现象严重;
白便率的判定:观察养殖区域内鱼类排便情况,计算养殖过程中出现白便的鱼的条数。
相关统计结果如下表1:
表1鱼苗生长情况统计表
结果分析:
1.通过上述分析可见,B组优于F至G组,其对于肝胆综合症、肠炎和白便控制均明显,一般来说,罗非鱼的抗病能力比较强,其采食量大,最容易发生的就是白便和肠炎,一般来说,罗非鱼发生了肠炎就容易产生白便,一般来说白便为肠道黏膜的脱落物,但是导致肠道黏膜的脱落的原因不仅仅是肠炎,其消化功能不佳也可能导致肠道黏膜的脱落。
通过实验可以发现,在F至G组中,分别缺失了大蒜素、山楂酊、生姜提取物,其白便现象没有完全抑制,说明生姜提取物、大蒜素、山楂酊基于其各自不同的作用,有着较为明显的功能侧重,其中大蒜素具有抗菌等作用,其对于肠炎等肠道疾病控制较有优势,山楂酊对于肠道健康和肝胆健康具有贡献,但是其需要在大蒜素、生姜提取物两者具有抗氧化、抗菌类物质的存在下才能表现最优的效果。
2.通过B组、A组、F至G组的对比可见,白术、黄芪对于鱼类的肠道健康、肝胆健康有着重要的作用。
3.通过B组、C组来看,采用复合提取的方式能够提高大蒜类提取物、生姜类提取物的药用效果,提高罗非鱼的日增重;在生姜中含有较多的油溶性的姜油、姜辣素,姜油能够提高大蒜素中有效成分的溶出,同时,姜油具有较好的抗氧化性,对大蒜素具有较好的稳定促进作用,抑制单独提取大蒜素导致的大蒜素不稳定。
通过C组、D组、E组,合适的提取溶剂是实现较好的药用效果的有效保证;采用乙醇和乙酸乙酯的配合,可提高极性油溶性产物的溶出,同时采用乙酸乙酯提高油溶性物质的溶出效率;通过两者配合,可以超过采用市购提取物的效果,并且该提取方法为传统的油溶性提取方法,适于厂家低成本生产。
申请人声明,本发明通过上述实施例来说明本发明的工艺方法,但本发明并不局限于上述工艺步骤,即不意味着本发明必须依赖上述工艺步骤才能实施。所属技术领域的技术人员应该明了,对本发明的任何改进,对本发明所选用原料的等效替换及辅助成分的添加、具体方式的选择等,均落在本发明的保护范围和公开范围之内。
Claims (9)
1.一种水产肠道肝胆修复制剂,其特征在于,包括主料、生姜提取物、大蒜素、山楂酊;所述主料为白术、黄芪的提取物;
所述主料、生姜提取物、大蒜素、山楂酊的重量比为1000:10~100:10~20:10~50。
2.根据权利要求1所述的水产肠道肝胆修复制剂,其特征在于,所述主料的制备方法为:将3000g白术和黄芪以干燥饮片的形式加水煎煮2次,合并煎液,过滤,加入乙醇使醇含量为60%,静置,分取上清液,滤过,回收乙醇,浓缩成为相对密度为1.05~1.1的浓缩膏;所述白术、黄芪的质量比为1:1~3。
3.根据权利要求1所述的水产肠道肝胆修复制剂,其特征在于,所述主料、生姜提取物、大蒜素、山楂酊的重量比为1000:20~70:12~16:20~40。
4.根据权利要求2所述的水产肠道肝胆修复制剂,其特征在于,将浓缩膏、生姜提取物、大蒜素、山楂酊、辅料混合,制粒;所述辅料为淀粉。
5.一种水产肠道肝胆修复制剂,其特征在于,包括主料、生姜大蒜混合提取物、山楂酊;所述主料为白术、黄芪的提取物;
所述主料、生姜大蒜混合提取物、山楂酊的重量比为1000:10~100:10~50。
6.根据权利要求5所述的产肠道肝胆修复制剂,其特征在于,所述生姜大蒜混合提取物的提取方法为:将新鲜的生姜、大蒜按照5:1~3的比例混合,采用粉碎机粉碎成混合物,采用90-95vol%的乙醇、乙酸乙酯作为提取溶剂提取混合物;乙醇、乙酸乙酯的体积比为6~9:1~4;混合物和提取溶剂的重量比为1:5~10;提取温度低于40℃,提取时间为3~5h;提取结束后经过滤、真空浓缩得到浸膏,将浸膏分散到乙酸乙酯中进行萃取,收集萃取后的油相,减压蒸馏去除乙酸乙酯,得到生姜大蒜混合提取物。
7.根据权利要求6所述的产肠道肝胆修复制剂,其特征在于,乙醇、乙酸乙酯的体积比为7~8:2~3;混合物和提取溶剂的重量比为1:6~8。
8.根据权利要求5所述的产肠道肝胆修复制剂,其特征在于,所述主料的制备方法为:将3000g白术和黄芪以干燥饮片的形式加水煎煮2次,合并煎液,过滤,加入乙醇使醇含量为60%,静置,分取上清液,滤过,回收乙醇,浓缩成为相对密度为1.05~1.1的浓缩膏所述白术、黄芪的质量比为1:1-3。
9.根据权利要求8所述的产肠道肝胆修复制剂,其特征在于,将浓缩膏、生姜大蒜混合提取物、山楂酊、辅料混合,制粒;所述辅料为淀粉。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311481357.1A CN117257911B (zh) | 2023-11-08 | 2023-11-08 | 一种水产肠道肝胆修复制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311481357.1A CN117257911B (zh) | 2023-11-08 | 2023-11-08 | 一种水产肠道肝胆修复制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117257911A true CN117257911A (zh) | 2023-12-22 |
CN117257911B CN117257911B (zh) | 2024-04-16 |
Family
ID=89208322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311481357.1A Active CN117257911B (zh) | 2023-11-08 | 2023-11-08 | 一种水产肠道肝胆修复制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117257911B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104938818A (zh) * | 2015-06-05 | 2015-09-30 | 湛江恒兴特种饲料有限公司 | 一种保护罗非鱼肠道健康的复方中草药饲料添加剂 |
CN106620567A (zh) * | 2015-11-02 | 2017-05-10 | 重庆安尚园农业科技发展有限公司 | 专用于治疗牛白痢病的饲料添加剂 |
CN114470084A (zh) * | 2022-01-06 | 2022-05-13 | 佛山市顺德区旺海饲料实业有限公司 | 环保高效防治罗非鱼白便的组合物及其制备方法和应用 |
-
2023
- 2023-11-08 CN CN202311481357.1A patent/CN117257911B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104938818A (zh) * | 2015-06-05 | 2015-09-30 | 湛江恒兴特种饲料有限公司 | 一种保护罗非鱼肠道健康的复方中草药饲料添加剂 |
CN106620567A (zh) * | 2015-11-02 | 2017-05-10 | 重庆安尚园农业科技发展有限公司 | 专用于治疗牛白痢病的饲料添加剂 |
CN114470084A (zh) * | 2022-01-06 | 2022-05-13 | 佛山市顺德区旺海饲料实业有限公司 | 环保高效防治罗非鱼白便的组合物及其制备方法和应用 |
Non-Patent Citations (2)
Title |
---|
姜芳燕;杨宁;冯慧敏;武耀廷;: "不同活性物质对大海马烂尾病病原菌的体外抑菌作用研究", 海南热带海洋学院学报, no. 05, 26 October 2017 (2017-10-26), pages 14 - 19 * |
朱晓兰, 吕春伟, 高芸: "山楂酊挥发性化合物的气相色谱-质谱分析", 卫生研究, no. 01, 20 January 2004 (2004-01-20), pages 108 - 110 * |
Also Published As
Publication number | Publication date |
---|---|
CN117257911B (zh) | 2024-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104054972B (zh) | 一种用于饲养河蟹的饲料 | |
WO2016202184A1 (zh) | 母猪产后配合饲料及其制备方法 | |
CN105410346A (zh) | 提高养殖对虾存活率的中药制剂及其制备方法 | |
CN104799045A (zh) | 一种黄沙鳖用饲料及其制备方法 | |
CN105250406A (zh) | 一种防治淡水鱼病毒性疾病的中草药发酵提取液及其制备方法 | |
CN105433025A (zh) | 一种保健土鸡饲料添加剂 | |
CN105360597B (zh) | 一种提升甲鱼品质的功能性药饵及其制备方法和投喂方法 | |
CN105995165A (zh) | 一种降低肉鸡发病率的饲料及其制作方法 | |
CN105747102A (zh) | 一种富含小麦低聚肽的即食益母草营养面条 | |
CN105010848A (zh) | 一种能降低特种野猪种母猪发病率的饲料及其制备方法 | |
CN117257911B (zh) | 一种水产肠道肝胆修复制剂 | |
CN103947857A (zh) | 一种适口甜味猪饲料及其制备方法 | |
CN106107070A (zh) | 一种中草药山羊饲料及其制作方法 | |
CN108497169A (zh) | 一种畜禽用中草药添加剂及其制备方法 | |
CN114470084A (zh) | 环保高效防治罗非鱼白便的组合物及其制备方法和应用 | |
CN107319139A (zh) | 一种石蛙蝌蚪饲料及其制备工艺 | |
CN112544812A (zh) | 一种产蛋后期蛋鸡用混菌发酵型中草药添加剂及其制备方法和应用 | |
CN106173240A (zh) | 一种肝脏保护功能复合植物提取物饲料添加剂及制备工艺 | |
CN105249001A (zh) | 一种对虾养殖的饲料添加剂 | |
CN105231093A (zh) | 一种提高对虾成活率的添加剂 | |
CN110637934A (zh) | 茶籽粕多糖复合物及其在饲料和治疗猪蓝耳病中的应用 | |
CN1301742C (zh) | 一种防治虾红体白斑,烂鳃,游池综合症的中药制剂 | |
CN111097020A (zh) | 一种防治虹鳟肠炎病的中草药制剂及其制备方法和应用 | |
CN115531471B (zh) | 一种抗非洲猪瘟的组合物及其制备方法和应用 | |
CN111920898B (zh) | 一种抗病毒处方及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |